PatientMatch — Privacy-first clinical trial discovery

Showing 1–24 of 36 trials

Enrolling now

Nationwide

A Study of BBT001

Bambusa Therapeutics

PHASE1·~2yr·1 site in NY

Why this is shown: Actively enrolling · PHASE1 · 1 site in NY

Enrolling now

Check if I qualify View study Official listing

Enrolling now

Check if I qualify

Nationwide

A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

AbbVie

PHASE3·~3yr·81 sites in AL, AR, AZ +24

Why this is shown: Actively enrolling · PHASE3 · 81 sites in AL, AR, AZ +24

Enrolling now

Check if I qualify View study Official listing

Enrolling now

Check if I qualify

Nationwide

A Study to Assess the Efficacy and Safety of Afimkibart (RO7790121) in Participants With Moderate to Severe Atopic Dermatitis

Hoffmann-La Roche

PHASE2·~1.5yr·25 sites in CA, FL, GA +12

Why this is shown: Actively enrolling · PHASE2 · 25 sites in CA, FL, GA +12

Enrolling now

Check if I qualify View study Official listing

Enrolling now

Check if I qualify

Nationwide

A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Single and Multiple Dose SC Injection in Patients With Moderate to Severe Atopic Dermatitis

Brexogen Inc.

PHASE1·~3yr·3 sites in AR, PA

Why this is shown: Actively enrolling · PHASE1 · 3 sites in AR, PA

Enrolling now

Check if I qualify View study Official listing

Enrolling now

Check if I qualify

Nationwide

A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis

Pfizer

PHASE2·~3yr·52 sites in AL, AZ, CA +16

Why this is shown: Actively enrolling · PHASE2 · 52 sites in AL, AZ, CA +16

Enrolling now

Check if I qualify View study Official listing

Enrolling now

Check if I qualify

Nationwide

A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic Dermatitis (Eczema) and High Itch Burden

Eli Lilly and Company

PHASE4·~16mo·35 sites in AL, AZ, CA +13

Why this is shown: Actively enrolling · PHASE4 · 35 sites in AL, AZ, CA +13

Enrolling now

Check if I qualify View study Official listing

Enrolling now

Check if I qualify

Nationwide

A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis

LEO Pharma

PHASE3·~4yr·15 sites in AL, AR, CA +7

Why this is shown: Actively enrolling · PHASE3 · 15 sites in AL, AR, CA +7

Enrolling now

Check if I qualify View study Official listing

Enrolling now

Check if I qualify

Nationwide

Dupilumab De-escalation in Pediatric Atopic Dermatitis

Johns Hopkins University

PHASE4·~3yr·1 site in MD

Why this is shown: Actively enrolling · PHASE4 · 1 site in MD

Enrolling now

Check if I qualify View study Official listing

Enrolling now

Check if I qualify

Nationwide

Ethnic Differences in Mechanisms of Action of Dupilumab

University of Michigan

PHASE4·~4yr·1 site in MI

Why this is shown: Actively enrolling · PHASE4 · 1 site in MI

Enrolling now

Check if I qualify View study Official listing

Enrolling now

Check if I qualify

Nationwide

FIH Study to Evaluate the Tolerability of PF-07832837

Pfizer

PHASE1·~3yr·3 sites in CA, FL, PA

Why this is shown: Actively enrolling · PHASE1 · 3 sites in CA, FL, PA

Enrolling now

Check if I qualify View study Official listing

Enrolling now

Check if I qualify

Nationwide

Lebrikizumab Trial for Atopic Dermatitis

Johann E Gudjonsson MD PhD

PHASE4·~2yr·2 sites in CA, MI

Why this is shown: Actively enrolling · PHASE4 · 2 sites in CA, MI

Enrolling now

Check if I qualify View study Official listing

Enrolling now

Check if I qualify

Nationwide

Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic Dermatitis

Northwestern University

PHASE4·~17mo·1 site in IL

Why this is shown: Actively enrolling · PHASE4 · 1 site in IL

Enrolling now

Check if I qualify View study Official listing

Enrolling now

Check if I qualify

Nationwide

A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis

Hoffmann-La Roche

PHASE2·~7yr·2 sites in MI, PA

Why this is shown: Actively enrolling · PHASE2 · 2 sites in MI, PA

Enrolling now

Check if I qualify View study Official listing

Enrolling now

Check if I qualify

Nationwide

A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis

AbbVie

PHASE3·~6yr·30 sites in AR, CA, FL +16

Why this is shown: Actively enrolling · PHASE3 · 30 sites in AR, CA, FL +16

Enrolling now

Check if I qualify View study Official listing

Enrolling now

Check if I qualify

Nationwide

A Study to Assess the Efficacy of GX-03 in Moderate to Severe Eczema (Atopic Dermatitis)

Turn Therapeutics

PHASE2·~12mo·1 site in TX

Why this is shown: Actively enrolling · PHASE2 · 1 site in TX

Enrolling now

Check if I qualify View study Official listing

Enrolling now

Check if I qualify

Nationwide

A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis

Inmagene LLC

PHASE2·~2yr·16 sites in CA, FL, IL +8

Why this is shown: Actively enrolling · PHASE2 · 16 sites in CA, FL, IL +8

Enrolling now

Check if I qualify View study Official listing

Enrolling now

Check if I qualify

Nationwide

A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis

Organon and Co

PHASE3·~2yr·38 sites in AL, AR, CA +21

Why this is shown: Actively enrolling · PHASE3 · 38 sites in AL, AR, CA +21

Enrolling now

Check if I qualify View study Official listing

Enrolling now

Check if I qualify

Nationwide

Cardamom and Topical Roseomonas in Atopic Dermatitis

National Institute of Allergy and Infectious Diseases (NIAID)

PHASE2·~15mo·1 site in MD

Why this is shown: Actively enrolling · PHASE2 · 1 site in MD

Enrolling now

Check if I qualify View study Official listing

Enrolling now

Check if I qualify

Nationwide

Dupixent and Narrowband UVB for Atopic Dermatitis

Psoriasis Treatment Center of Central New Jersey

PHASE4·~3yr·1 site in NJ

Why this is shown: Actively enrolling · PHASE4 · 1 site in NJ

Enrolling now

Check if I qualify View study Official listing

Enrolling now

Check if I qualify

Nationwide

Michigan Food and Atopic Dermatitis (M-FAD) Program - Molecular Analytics Project

University of Michigan

~3yr·1 site in MI

Why this is shown: Actively enrolling · 1 site in MI

Enrolling now

Check if I qualify View study Official listing

Enrolling now

Check if I qualify

Nationwide

Platform Trial for Atopic Dermatitis

Novartis Pharmaceuticals

PHASE2·~4yr·22 sites in AL, AR, CA +9

Why this is shown: Actively enrolling · PHASE2 · 22 sites in AL, AR, CA +9

Enrolling now

Check if I qualify View study Official listing

Enrolling now

Check if I qualify

Nationwide

Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)

National Institute of Allergy and Infectious Diseases (NIAID)

PHASE1·~1.5yr·8 sites in CA, CO, IL +3

Why this is shown: Actively enrolling · PHASE1 · 8 sites in CA, CO, IL +3

Enrolling now

Check if I qualify View study Official listing

Enrolling now

Check if I qualify

Nationwide

A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab

AbbVie

PHASE2·~3yr·2 sites in CA, MI

Why this is shown: Actively enrolling · PHASE2 · 2 sites in CA, MI

Enrolling now

Check if I qualify View study Official listing

Enrolling now

Check if I qualify

Nationwide

Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD

Corvus Pharmaceuticals, Inc.

PHASE2·1 site in CA

Why this is shown: Actively enrolling · PHASE2 · 1 site in CA

Enrolling now

Check if I qualify View study Official listing

Enrolling now

Check if I qualify